This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
News|Articles|June 2, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-06-07-2016
- Volume 11
- Issue 6
FUJIFILM Opens New Laboratory in North Carolina
Author(s)Pharmaceutical Technology Editors
The company opened its 62,000 square foot facility, called the BioProcess Innovation Center, in Triangle Park, NC.
Advertisement
FUJIFILM Diosynth Biotechnologies completed construction on a new three-story, 62,000-square-foot facility in Research Triangle Park, NC. A ribbon cutting ceremony was held on May 9, 2016, the company said in a
Source:
Articles in this issue
over 10 years ago
Slow Serialization Efforts May Delay Business Benefitsover 10 years ago
Scientific Approach Ensures Accurate Weighing Resultsover 10 years ago
Ensuring Biologic API Uniformityover 10 years ago
Biomanufacturing Outsourcing Budgets Grow, Slowlyover 10 years ago
Novasep Starts Kilogram-Scale Batch Production at US Facilityover 10 years ago
Catalent Opens Korean Sales Officeover 10 years ago
Juniper Pharma Services Expands Topicals Capacityover 10 years ago
ED-XRF Spectrometers Offer Rapid Elemental Analysisover 10 years ago
Raman Microscope Measures Uneven Surfacesover 10 years ago
Particle Analyzer Based on Light ScatteringAdvertisement
Related to this article
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Advertisement
Advertisement